Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: A survey of the European experience, 1985-2000

Blood

Volumn 100, Issue 13, 2002, Pages 4344-4350

  Seger, Reinhard A ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Gungor, Tayfun ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Belohradsky, Bernd H ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Blanche, Stephane ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Bordigoni, Pierre ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Di Bartolomeo, Paolo ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Flood, Terence ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Landais, Paul ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Müller, Susanna ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Ozsahin, Hulya ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Passwell, Justen H ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Porta, Fulvio ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Slavin, Shimon ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Wulffraat, Nico ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Zintl, Felix ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Nagler, Arnon ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Cant, Andrew ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Fischer, Alain ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a Eur Grp Blood/Marrow Transplant   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f Ospedale Civile di Pescara   (Italy)

^g NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITAL ULM   (Germany)

ⁱ SHEBA MEDICAL CENTER   (Israel)

^j UNIVERSITY OF BRESCIA   (Italy)

^k HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; HLA ANTIGEN;

ADOLESCENT; ADULT; APLASIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EUROPE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INFANT; INFECTION; INFLAMMATION; LIVING DONOR; MALE; PRIORITY JOURNAL; RISK FACTOR; SIBLING; SURVIVAL; TREATMENT OUTCOME;

EID: 0037114622     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0583     Document Type: Article

References (30)

1. Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162:723-726.
2. Mouy R, Veber F, Blanche S, et al. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr. 1994;125:998-1003.
3. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med. 1991;324:509-516.
4. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease: Report on a national registry of 368 patients. Medicine. 2000;79:155-169.
5. Ozsahin H, von Planta M, Müller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood. 1998;92:2719-2724.
6. Bielorai B, Toren A, Wolach B, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant. 2000;26:1025-1028.
7. Di Bartolomeo P, Di Girolamo G, Angrilli F, et al. Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant. 1989;4:695-700.
8. Nagler A, Ackerstein A, Kapelushnik J, Or R, Naparstek E, Slavin S. Donor lymphocyte infusion post-nonmyeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant. 1999;24:339-342.
9. Zintl F, Hermann J, Fuchs D, et al. Korrektur letal verlaufender genetischer erkrankungen mit hilfe der knochenmarktransplantation. Kinderärztl Praxis. 1991;59:10-15.
10. Hobbs JR, Monteil M, McCluskey DR, Jurges E, El Tumi M. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr. 1992;151:806-810.
11. Calviño MC, Madonado MS, Otheo E, Muñoz A, Couselo JM, Burgaleta C. Bone marrow transplantation in chronic granulomatous disease. Eur J Pediatr. 1996;155:877-879.
12. Slavin S, Nagler A, Naparstek E, et al. Nonmyloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood. 1998;91:756-763.
13. McSweeney PA, Storb R. Mixed chimerism: Preclinical studies and clinical applications. Biol Blood Marrow Transplant. 1999;5:192-203.
14. Horwitz ME, Barrett J, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med. 2001;344:881-888.
15. Cale CM, Jones AM, Goldblatt D. Outcome of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol. 2000;120:1-6.
16. Forster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest. 1998;102:2146-2155.
17. Rappeport JM, Newburger PE, Goldblum RM, Goldman AS, Nathan DG, Parkman R. Allogeneic bone marrow transplantation for chronic granulomatous disease. J Pediatr. 1982;101:952-955.
18. Kamani N, August CS, Douglas SD, Burkey E, Etzioni A, Lischner HW. Bone marrow transplantation in chronic granulomatous disease. J Pediatr. 1984;105:42-46.
19. Kamani N, August CS, Campbell DE, Hassan NF, Douglas SD. Marrow transplantation in chronic granulomatous disease: An update, with 6-year follow-up. J Pediatr. 1988;113:697-700.
20. Ho CML, Vowels MR, Lockwood L, Ziegler JB. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant. 1996;18:213-215.
21. Akioka S, Itoh H, Ueda I, et al. Donor lymphocyte infusion at unstable mixed chimerism in an allogeneic BMT recipient for chronic granulomatous disease. Bone Marrow Transplant. 1998;22:609-611.
22. Leung TF, Chik KW, Li CK, Shing MMK, Yuen PMP. Bone marrow transplantation for chronic granulomatous disease: Long-term follow-up and review of literature. Bone Marrow Transplant. 1999;24:567-570.
23. Morgenstern DE, Gifford MAC, Lin Li L, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease and inflammatory response to Aspergillus fumigatus. J Exp Med. 1997;185:207-218.
24. Van Deventer SJ. Tumor necrosis factor and Crohn's disease. Gut. 1997;40:443-448.
25. Hilt GR, Teshima T, Rebel VI, et al. The p55 TNF-α receptor plays a critical role in T cell alloreactivity. J Immunol. 2000;164:656-663.
26. Rollides E, Dimitriadou-Georgiadou A, Sein T, Kadittsoglou I, Walsh TJ. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun. 1998;66:5999-6003.
27. Schelenz S, Smith DA, Bancroft GJ. Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus: Obligatory role of TNF-α and GM-CSF in neutrophil recruitment. Med Mycol. 1999;37:183-194.
28. Güngör T, Engel-Bicik I, Eich G, et al. Diagnostic and therapeutic impact of whole body positron emission tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease. Arch Dis Child. 2001;85:341-345.
29. Cavazzana-Calvo M, Stephan JL, Sarnacki S, et al. Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood. 1994:83:288-298.
30. Hasui M. Chronic granulomatous disease in Japan: Incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int. 1999;41:589-593.